Also categorized in Information:
Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project - Meany - 2014 - Pediatric Blood & Cancer
x hide permanently

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.

ncbi.nlm.nih.gov

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.

Korean J Pediatr. 2018 Feb;61(2):53-58

Authors: Kim C, Choi YB, Lee JW, Yoo KH, Sung KW, Koo HH

Abstract Purpose: Although the prognosis is generally good in patients with intermediate-risk neuroblastoma, no consensus has been reached on the ideal treatment regimen.